President Donald Trump signed the Trump women's health executive order on Monday, creating a Women’s Health Division at the National Institutes of Health and a White House task force to address gaps in women’s health research. The order also puts the effort on a same-day track: the task force was set to hold its first meeting Monday.
Rose Garden remarks from Melania Trump
First Lady Melania Trump helped shape the initiative and described it in the Rose Garden as “a transformative moment for women in America.” She said advances in science and greater openness around once-taboo subjects create an opportunity to “reinvent women’s healthcare.”
She also said, “Previous generations fought for women’s rights. Our generation will fight to discover the cures that will ensure a woman can live her life in health and to the fullest.” Trump said she outlined five pillars of women’s health innovation during her remarks.
Susie Wiles and Robert F. Kennedy Jr.
Trump said White House chief of staff Susie Wiles and Health and Human Services Secretary Robert F. Kennedy Jr. will lead the task force. He called Wiles “a tremendous fighter” and said she cares deeply about improving women’s health. Trump also said Melania Trump made “an outstanding contribution” to the well-being of American children and families and brought “extraordinary leadership and skills” to improving women’s health.
The order identifies research priorities that include cardiovascular disease, cancer, stroke, Alzheimer’s disease, autoimmune and inflammatory conditions, osteoporosis, mental health, chronic pain, endometriosis, fibroids, polyendocrine metabolic ovary syndrome, infertility, maternal health, menopause, neurological disorders and aging. It says the new effort will focus on translating research into improved clinical care.
Prior women’s health initiatives
The order rescinds women’s health initiatives from the prior administration while presenting the new structure as a push to close research gaps. That leaves the new division and task force with a clear federal mandate, but the practical test is whether the research agenda turns into clinical changes that patients can notice.
Monday also fell during Breast Cancer Awareness Month, which made the timing of the announcement fit the subject the order is meant to address. The next question is not whether the government now has a name for the effort, but which policies or programs the new division and task force will actually put in place.
